Safety and Efficacy Study of DCVax-Direct in Solid Tumors
NCT01882946
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced Tumor
Metastatic Solid Tissue Tumors
Liver Cancer
Colorectal Cancer
Pancreatic Cancer
Melanoma
Interventions
BIOLOGICAL:
DCVax-Direct
Sponsor
Northwest Biotherapeutics